BRUKER CORPORATION Oci Equity Method Investment After Tax Parent
BRUKER CORPORATION (BRKR) reported Oci Equity Method Investment After Tax Parent of $1.00 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-01.
Discontinued › Income Statement › Other Income
us-gaap:OciEquityMethodInvestmentAfterTaxParent · last filed 2023-03-01
- BRUKER CORPORATION oci equity method investment after tax parent for the quarter ending 2022-12-31 was $700.00K.
- BRUKER CORPORATION oci equity method investment after tax parent for the quarter ending 2022-09-30 was $300.00K.
- BRUKER CORPORATION oci equity method investment after tax parent for the quarter ending 2021-12-31 was $0.00.
- BRUKER CORPORATION oci equity method investment after tax parent for the quarter ending 2021-09-30 was $0.00.
- BRUKER CORPORATION oci equity method investment after tax parent for fiscal 2022 was $1.00M.
- BRUKER CORPORATION oci equity method investment after tax parent for fiscal 2021 was $0.00.
- BRUKER CORPORATION oci equity method investment after tax parent for fiscal 2020 was $0.00.
| Period end | Oci Equity Method Investment After Tax Parent 3 month | Oci Equity Method Investment After Tax Parent 6 month | Oci Equity Method Investment After Tax Parent 9 month | Oci Equity Method Investment After Tax Parent 12 month |
|---|---|---|---|---|
| 2022-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $1.00M derived: sum of 2 quarters · filed 2023-03-01 | $1.00M 10-K · filed 2023-03-01 | |
| 2022-09-30 | $300.00K 10-Q · filed 2022-11-04 | $300.00K 10-Q · filed 2022-11-04 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $0.00 derived: sum of 2 quarters · filed 2023-03-01 | $0.00 10-K · filed 2023-03-01 | |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-04 | $0.00 10-Q · filed 2022-11-04 | ||
| 2020-12-31 | $0.00 10-K · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |